Zobrazeno 1 - 10
of 102
pro vyhledávání: '"Milijašević, Boris"'
Autor:
Maletin Sanja D., Maletin Srđan M., Baltić Milan V., Krtinić Dane A., Mićanović Branimir B., Todorović Nemanja B., Milijašević Boris Ž.
Publikováno v:
Hospital Pharmacology, Vol 11, Iss 2, Pp 1449-1455 (2024)
Introduction: Heart failure is characterized by a high prevalence both in our country and in the world. Patients with heart failure have an impaired quality of life, are prone to rehospitalization and have a higher mortality rate. Adequate pharmacoth
Externí odkaz:
https://doaj.org/article/017e3feb23914a07aabed037b0393f1c
Autor:
Todorović, Nemanja, Čanji Panić, Jelena, Pavlić, Branimir, Popović, Senka, Ristić, Ivan, Rakić, Srđan, Rajšić, Ivana, Vukmirović, Saša, Srđenović Čonić, Branislava, Milijašević, Boris, Milošević, Nataša, Lalić-Popović, Mladena
Publikováno v:
In International Journal of Pharmaceutics 5 January 2024 649
Autor:
Knežević Violeta V., Knežević Aleksandar D., Milijašević Dragana S., Božić Dušan Đ., Milijašević Boris Ž.
Publikováno v:
Hospital Pharmacology, Vol 10, Iss 3, Pp 1349-1355 (2023)
Introduction: Megacystis-microcolon-intestinal hypoperistalsis syndrome (MMIHS) is a very rare genetic disorder of visceral motility of the gastrointestinal and genitourinary system. According to our knowledge, so far there has been no description of
Externí odkaz:
https://doaj.org/article/efd1874584d547f5b184d36d988ec6a9
Autor:
Milijašević Boris Ž., Milak Anđela D., Ubavić Milan B., Krtinić Dane A., Nedin-Ranković Gorana G., Jovanović Hristina M., Trajković Hristina S., Milijašević Dragana S., Popović Radmila N., Todorović Nemanja B., Lalić-Popović Mladena N., Vukosav Nikola B., Baljak Branko M., Tošić Milan S., Matijević Radmila N.
Publikováno v:
Hospital Pharmacology, Vol 10, Iss 2, Pp 1301-1313 (2023)
Introduction: The policy concerning drugs represents a concentrated effort to achieve better health outcomes for all, with a particular focus on people's access to and rational use of medications. On the basis of pharmacoeconomic analyses, it is poss
Externí odkaz:
https://doaj.org/article/44fffb3e67424d92a02414813df5b99d
Autor:
Vuković Milana M., Vesković Dunja M., Todorović Nemanja B., Roš Tatjana N., Jovanović-Ljubičić Jasmina M., Kuzman Danilo D., Lalić-Popović Mladena N., Miljković Dejan M., Milijašević Boris Ž.
Publikováno v:
Hospital Pharmacology, Vol 10, Iss 1, Pp 1250-1263 (2023)
Introduction: According to the ATC system of drug classification, group R06 includes H1 antihistamines for systemic use, which are divided into drug groups of the 1st and 2nd generation. Aim: Since there are no national guidelines in Serbia, for trea
Externí odkaz:
https://doaj.org/article/8b39af99ea3344449f028f6671350cc1
Autor:
Krtinić, Dane1,2 dane.krtinic@medfak.ni.ac.rs, Milijašević, Boris3, Dragić, Aleksandra3, Milijašević, Dragana4,5, Prokin, Aleksandra Lučić4,6, Ranković, Gorana Nedin1, Conić, Irena2,7, Mitić, Mirjana Todorović2, Jovanović, Hristina1, Trajković, Hristina1, Pejčić, Vuk8
Publikováno v:
Acta Facultatis Medicae Naissensis. 2024, Vol. 41 Issue 1, p102-119. 18p.
Autor:
Rajšić Ivana, Pavlović Nebojša, Milijašević Boris, Vukmirović Saša, Spasić Dragan, Žigić Miodrag, Grahovac Nenad, Goločorbin-Kon Svetlana, Mikov Momir
Publikováno v:
Vojnosanitetski Pregled, Vol 78, Iss 7, Pp 708-715 (2021)
Background/Aim. Methotrexate (MTX) plays a significant role in the treatment of various diseases, but the toxicity remains the main issue of its use, especially when administered in high doses. Considering altered pharmacokinetics of MTX as a factor
Externí odkaz:
https://doaj.org/article/8f9e946c89fe4f18a1187d6571a51693
Autor:
Martić Nikola B., Zečević Dragan D., Đurđević Milena V., Milijašević Dragana S., Tomić Nataša Z., Lalić-Popović Mladena N., Todorović Nemanja B., Medin Danilo V., Mićanović Branimir B., Milijašević Boris Ž.
Publikováno v:
Hospital Pharmacology, Vol 7, Iss 3, Pp 966-975 (2020)
Introduction: Cardiovascular diseases are the leading cause of death both in Serbia and in the rest of the world. It has been shown that as many as 80% of them are preventable. Control of serum lipid levels is one of the most important tasks of cardi
Externí odkaz:
https://doaj.org/article/a2976d05315e4f4aa5f52fa4f9f336ab
Autor:
Jović Jelena, Milijašević Boris, Vukmirović Saša, Vasović Velibor, Mikov Momir, Mooranian Armin, Al-Salami Hani, Golocorbin-Kon Svetlana
Publikováno v:
Scripta Medica, Vol 51, Iss 1, Pp 15-20 (2020)
Background/Aim: Gliclazide is one of the most commonly prescribed oral anti-hyperglycaemic therapies in type 2 diabetes mellitus (T2D). Recently reported additional beneficial pharmacological properties of gliclazide, including immunomodulatory and a
Externí odkaz:
https://doaj.org/article/4b13049ff9ad45f7912c81092b242fa1
Autor:
Bajić Dejana D., Todorović Nemanja B., Eić Nikola M., Lalić-Popović Mladena N., Milijašević Boris Ž.
Publikováno v:
Hospital Pharmacology, Vol 7, Iss 1, Pp 868-874 (2020)
Introduction: Community-acquired pneumonia is one of the most common diseases in infancy but most of these diseases have relatively simple course. We are presenting a case of child who developed lung abscess as a complication of pneumonia. Case Repor
Externí odkaz:
https://doaj.org/article/0212d966f56a421e94a5964b69cd6c0c